5VJ3
HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site
Summary for 5VJ3
Entry DOI | 10.2210/pdb5vj3/pdb |
Related | 5TO9 |
Descriptor | Protease, 4-methyl-N-({1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl}carbamoyl)benzene-1-sulfonamide, MAGNESIUM ION, ... (4 entities in total) |
Functional Keywords | protease, allostery, fragment binding, eye site, hydrolase |
Biological source | Human immunodeficiency virus 1 |
Total number of polymer chains | 1 |
Total formula weight | 11235.45 |
Authors | Tiefenbrunn, T.,Stout, C.D. (deposition date: 2017-04-18, release date: 2018-04-18, Last modification date: 2023-10-04) |
Primary citation | Forli, S.,Tiefenbrunn, T.,Baksh, M.M.,Chang, M.W.,Perryman, A.,Garg, D.,Happer, M.,Lin, Y.-C.,Goodsell, D.,Angelina, E.L.,De Vera, I.,Kojetin, D.,Torbett, B.E.,Finn, M.G.,Elder, J.,Stout, C.D.,Olson, A. Fragment-based campaign for the identification of potential exosite binders of HIV-1 Protease to be published, |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report